Life Science Disruptors →
Head of global research and development at Life Technologies
President & CEO, Indiana Biosciences Research Institute
President and CEO of the Central Indiana Corporate Partnership
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
CEO and Fund Manager, Renaissance Venture Capital Fund
Founder and CEO of Brooks Bell Inc.
October 17, 2018 · Boston
November 4, 2018 · Boston
December 5, 2018 · San Francisco
Walter Ogier is the president and CEO of Acetylon Pharmaceuticals
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Robust ecosystem supports tech hub and startup community
Early-stage startups compete for the title of Startup of the Year
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.